Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H41NO9.ClH |
| Molecular Weight | 536.055 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@@H]1[C@@]3([C@@H]5C[C@@]6(O)[C@H](O)[C@@H]5[C@]4(O)[C@@H](O)[C@@H]6OC)[C@H](C[C@H]2O)OC
InChI
InChIKey=VYCYKIMOQJFYBT-QLAPATKWSA-N
InChI=1S/C25H41NO9.ClH/c1-6-26-9-22(10-32-2)12(27)7-13(33-3)24-11-8-23(30)19(28)14(11)25(31,20(29)21(23)35-5)15(18(24)26)16(34-4)17(22)24;/h11-21,27-31H,6-10H2,1-5H3;1H/t11-,12-,13+,14-,15+,16+,17-,18-,19-,20+,21+,22+,23-,24+,25-;/m1./s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: map04064 |
|||
Target ID: NFATc1 activation Sources: https://www.ncbi.nlm.nih.gov/pubmed/26592521 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
164512915
Created by
admin on Wed Apr 02 11:19:10 GMT 2025 , Edited by admin on Wed Apr 02 11:19:10 GMT 2025
|
PRIMARY | |||
|
R6WPG9KYE3
Created by
admin on Wed Apr 02 11:19:10 GMT 2025 , Edited by admin on Wed Apr 02 11:19:10 GMT 2025
|
PRIMARY | |||
|
107801-58-1
Created by
admin on Wed Apr 02 11:19:10 GMT 2025 , Edited by admin on Wed Apr 02 11:19:10 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD